Capital Raise in Cancer Genomics | Biotech Investment & SDG 3 Explained

In this episode: Capital Raise in Cancer Genomics | Biotech Investment & SDG 3 Explained

In this video, we explore a capital raise in a pre-public cancer research company, highlighting the critical role of biotechnology, life sciences, and Sustainable Development Goal 3 (Good Health & Well-Being).

We discuss how genomic testing in preclinical models (mice) is used to study chromosomes and predict potential outcomes in humans. This research is crucial for advancing cancer treatment and precision medicine.

Key points covered in this video:
• Capital raising strategies in biotech and life sciences
• Cancer research funding and genomic innovation
• Sustainable Development Goal 3 (SDG 3) and its impact on healthcare
• Preclinical genomic testing and potential human applications
• Future opportunities in biotech investment and precision medicine

📌 Don’t forget to Like, Comment, and Subscribe for more videos on biotech, healthcare innovation, and investment opportunities!

#CancerResearch #BiotechInvestment #Genomics #SDG3 #LifeSciences #HealthcareInnovation #PrecisionMedicine #CapitalRaise #Biotechnology #InvestmentOpportunities #planetgold

Видео Capital Raise in Cancer Genomics | Biotech Investment & SDG 3 Explained канала PLANET GOLD